Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.42
-0.29 (-0.63%)
At close: Oct 5, 2026, 4:00 PM EDT
45.66
+0.23 (0.52%)
After-hours: Oct 5, 2026, 7:30 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $130.54 million as of October 5, 2026. Its market cap has increased by 2,528.61% in one year.
Market Cap
130.54M
Enterprise Value
41.91M
1-Year Change
2,528.61%
Ranking
Category
Stock Price
$45.42
ChartMarket Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $130.54M, a decrease of -65.51%. That is a compound annual growth rate of -16.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 131.21M | 40.73% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 138.78M |
| PMV Pharmaceuticals | 135.17M |
| Atrium Therapeutics | 134.11M |
| Armata Pharmaceuticals | 130.88M |
| Caribou Biosciences | 130.79M |
| Cibus | 130.69M |
| enGene Therapeutics | 130.01M |
| Kazia Therapeutics | 127.03M |